Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Postinjury thromboxane receptor blockade ameliorates acute lung injury
Charles D. Goff
, R. Scott Corbin
, Steven D. Theiss
, Henry F. Frierson
, Gerald A. Cephas
, Curtis G. Tribble
, Irving L. Kron
, Jeffrey S. Young
Medicine Administration
Research output
:
Contribution to journal
›
Article
›
peer-review
33
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Postinjury thromboxane receptor blockade ameliorates acute lung injury'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Lung Injury
100%
Receptor Blockade
100%
Oleic Acid
100%
Thromboxane Receptor
100%
Saline Control
60%
Injury Control
60%
Acid Infusion
40%
Oxygenation
40%
Acid Activation
40%
Lung
40%
Pulmonary Hypertension
40%
Thrombin Receptor Antagonist
40%
Thromboxane A2 Receptor
40%
Oxygen Capacity
40%
Pulmonary Artery Pressure
20%
Treatment Group
20%
Heart-lung
20%
Oxygen Tension
20%
Beneficial Effects
20%
Rabbit Heart
20%
Vascular Permeability
20%
Saline Solution
20%
Ex Vivo Perfusion
20%
Pulmonary Hemodynamics
20%
Thromboxane A2 (TXA2)
20%
Ventilation System
20%
Aqueous Ethanol
20%
Isolated Lung Model
20%
Intrapulmonary Shunting
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
100%
Thromboxane Receptor
100%
Oleic Acid
100%
Sodium Chloride
60%
Injury
60%
Pulmonary Hypertension
40%
Thromboxane A2 Receptor
40%
Thromboxane Receptor Blocking Agent
40%
Receptor
20%
Ethanol
20%
Leporidae
20%
Thromboxane A2
20%
Nursing and Health Professions
Thromboxane A2 Receptor
40%
Medicine and Dentistry
Thromboxane A2 Receptor
40%